Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2 on the page, with no changes to study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:50:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.3.1 instead of v3.2.0. No study data, page text, or links were altered.
    Difference
    0.1%
    Check dated 2025-11-24T13:35:32.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the site-wide government funding and operating status notice from the page; this change does not affect the trial data, eligibility, or study results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:27:17.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The new screenshot shows a similar Record History page with updated visuals while preserving the same version list and study details; no substantive data changes are visible. This seems to be a UI refresh rather than a change to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:12:10.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    9%
    Check dated 2025-10-05T10:05:37.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:09:37.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.